Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Editor's Note: Cotreatment with STI-571 Enhances Tumor Necrosis Factor α-related Apoptosis-inducing Ligand (TRAIL or Apo-2L)-induced Apoptosis of Bcr-Abl-positive Human Acute Leukemia Cells.

Nimmanapalli R, Porosnicu M, Nguyen D, Worthington E, O'Bryan E, Perkins C, Bhalla K.

Clin Cancer Res. 2019 Jul 1;25(13):4195. doi: 10.1158/1078-0432.CCR-19-1602. No abstract available.

PMID:
31263034
2.

Curcumin attenuation of lipopolysaccharide induced cardiac hypertrophy in rodents.

Chowdhury R, Nimmanapalli R, Graham T, Reddy G.

ISRN Inflamm. 2013 Oct 21;2013:539305. doi: 10.1155/2013/539305. eCollection 2013.

3.

Cell-type-specific innate immune response to oncolytic Newcastle disease virus.

Biswas M, Kumar SR, Allen A, Yong W, Nimmanapalli R, Samal SK, Elankumaran S.

Viral Immunol. 2012 Aug;25(4):268-76. doi: 10.1089/vim.2012.0020. Epub 2012 Jul 18.

4.

ATP analog enhances the actions of a heat shock protein 90 inhibitor in multiple myeloma cells.

Cervantes-Gomez F, Nimmanapalli R, Gandhi V.

J Pharmacol Exp Ther. 2011 Nov;339(2):545-54. doi: 10.1124/jpet.111.184903. Epub 2011 Aug 5.

5.

Immunomodulation of caprine lentiviral infection by interleukin-16.

Nimmanapalli R, Sharmila C, Reddy PG.

Comp Immunol Microbiol Infect Dis. 2010 Dec;33(6):529-36. doi: 10.1016/j.cimid.2009.09.003. Epub 2009 Oct 7.

PMID:
19811834
6.

Transcription inhibition of heat shock proteins: a strategy for combination of 17-allylamino-17-demethoxygeldanamycin and actinomycin d.

Cervantes-Gomez F, Nimmanapalli R, Gandhi V.

Cancer Res. 2009 May 1;69(9):3947-54. doi: 10.1158/0008-5472.CAN-08-4406. Epub 2009 Apr 21.

7.

Targeting MET transcription as a therapeutic strategy in multiple myeloma.

Phillip CJ, Stellrecht CM, Nimmanapalli R, Gandhi V.

Cancer Chemother Pharmacol. 2009 Mar;63(4):587-97. doi: 10.1007/s00280-008-0770-2. Epub 2008 May 29.

8.

HSP70 inhibition reverses cell adhesion mediated and acquired drug resistance in multiple myeloma.

Nimmanapalli R, Gerbino E, Dalton WS, Gandhi V, Alsina M.

Br J Haematol. 2008 Aug;142(4):551-61. doi: 10.1111/j.1365-2141.2008.07217.x. Epub 2008 May 22.

9.

Bone marrow stroma confers resistance to Apo2 ligand/TRAIL in multiple myeloma in part by regulating c-FLIP.

Perez LE, Parquet N, Shain K, Nimmanapalli R, Alsina M, Anasetti C, Dalton W.

J Immunol. 2008 Feb 1;180(3):1545-55.

10.

The growth factor fusion construct containing B-lymphocyte stimulator (BLyS) and the toxin rGel induces apoptosis specifically in BAFF-R-positive CLL cells.

Nimmanapalli R, Lyu MA, Du M, Keating MJ, Rosenblum MG, Gandhi V.

Blood. 2007 Mar 15;109(6):2557-64. Epub 2006 Nov 21.

PMID:
17119117
11.

Forodesine, an inhibitor of purine nucleoside phosphorylase, induces apoptosis in chronic lymphocytic leukemia cells.

Balakrishnan K, Nimmanapalli R, Ravandi F, Keating MJ, Gandhi V.

Blood. 2006 Oct 1;108(7):2392-8. Epub 2006 Jun 15.

12.

Characterization of a R115777-resistant human multiple myeloma cell line with cross-resistance to PS-341.

Buzzeo R, Enkemann S, Nimmanapalli R, Alsina M, Lichtenheld MG, Dalton WS, Beaupre DM.

Clin Cancer Res. 2005 Aug 15;11(16):6057-64.

13.

Identification of compounds that enhance the anti-lymphoma activity of rituximab using flow cytometric high-content screening.

Gasparetto M, Gentry T, Sebti S, O'Bryan E, Nimmanapalli R, Blaskovich MA, Bhalla K, Rizzieri D, Haaland P, Dunne J, Smith C.

J Immunol Methods. 2004 Sep;292(1-2):59-71.

PMID:
15350512
14.

Arsenic trioxide inhibits translation of mRNA of bcr-abl, resulting in attenuation of Bcr-Abl levels and apoptosis of human leukemia cells.

Nimmanapalli R, Bali P, O'Bryan E, Fuino L, Guo F, Wu J, Houghton P, Bhalla K.

Cancer Res. 2003 Nov 15;63(22):7950-8.

15.

Histone deacetylase inhibitor LAQ824 both lowers expression and promotes proteasomal degradation of Bcr-Abl and induces apoptosis of imatinib mesylate-sensitive or -refractory chronic myelogenous leukemia-blast crisis cells.

Nimmanapalli R, Fuino L, Bali P, Gasparetto M, Glozak M, Tao J, Moscinski L, Smith C, Wu J, Jove R, Atadja P, Bhalla K.

Cancer Res. 2003 Aug 15;63(16):5126-35.

16.

Targets in apoptosis signaling: promise of selective anticancer therapy.

Nimmanapalli R, Bhalla K.

Methods Mol Biol. 2003;223:465-83. Review. No abstract available.

PMID:
12777745
17.

Molecular determinants of epothilone B derivative (BMS 247550) and Apo-2L/TRAIL-induced apoptosis of human ovarian cancer cells.

Griffin D, Wittmann S, Guo F, Nimmanapalli R, Bali P, Wang HG, Bhalla K.

Gynecol Oncol. 2003 Apr;89(1):37-47.

PMID:
12694652
18.

Regulation of 17-AAG-induced apoptosis: role of Bcl-2, Bcl-XL, and Bax downstream of 17-AAG-mediated down-regulation of Akt, Raf-1, and Src kinases.

Nimmanapalli R, O'Bryan E, Kuhn D, Yamaguchi H, Wang HG, Bhalla KN.

Blood. 2003 Jul 1;102(1):269-75. Epub 2003 Mar 6.

PMID:
12623837
19.

Flavopiridol down-regulates antiapoptotic proteins and sensitizes human breast cancer cells to epothilone B-induced apoptosis.

Wittmann S, Bali P, Donapaty S, Nimmanapalli R, Guo F, Yamaguchi H, Huang M, Jove R, Wang HG, Bhalla K.

Cancer Res. 2003 Jan 1;63(1):93-9.

20.

Inhibition of Bcr-Abl kinase activity by PD180970 blocks constitutive activation of Stat5 and growth of CML cells.

Huang M, Dorsey JF, Epling-Burnette PK, Nimmanapalli R, Landowski TH, Mora LB, Niu G, Sinibaldi D, Bai F, Kraker A, Yu H, Moscinski L, Wei S, Djeu J, Dalton WS, Bhalla K, Loughran TP, Wu J, Jove R.

Oncogene. 2002 Dec 12;21(57):8804-16.

21.

Novel targeted therapies for Bcr-Abl positive acute leukemias: beyond STI571.

Nimmanapalli R, Bhalla K.

Oncogene. 2002 Dec 9;21(56):8584-90. Review.

22.
23.

Mechanisms of resistance to imatinib mesylate in Bcr-Abl-positive leukemias.

Nimmanapalli R, Bhalla K.

Curr Opin Oncol. 2002 Nov;14(6):616-20. Review.

PMID:
12409651
24.
25.

Ectopic expression of protein-tyrosine kinase Bcr-Abl suppresses tumor necrosis factor (TNF)-induced NF-kappa B activation and IkappaBalpha phosphorylation. Relationship with down-regulation of TNF receptors.

Mukhopadhyay A, Shishodia S, Suttles J, Brittingham K, Lamothe B, Nimmanapalli R, Bhalla KN, Aggarwal BB.

J Biol Chem. 2002 Aug 23;277(34):30622-8. Epub 2002 Jun 11.

26.

Recent advances in Philadelphia chromosome-positive malignancies: the potential role of arsenic trioxide.

O'Dwyer ME, La Rosée P, Nimmanapalli R, Bhalla KN, Druker BJ.

Semin Hematol. 2002 Apr;39(2 Suppl 1):18-21. Review.

PMID:
12012318
27.
28.

Co-treatment with As2O3 enhances selective cytotoxic effects of STI-571 against Brc-Abl-positive acute leukemia cells.

Porosnicu M, Nimmanapalli R, Nguyen D, Worthington E, Perkins C, Bhalla KN.

Leukemia. 2001 May;15(5):772-8.

30.

Supplemental Content

Loading ...
Support Center